DOPAMINE D3 RECEPTOR LIGANDS FOR TREATMENT OF SUBSTANCE ABUSE

用于治疗药物滥用的多巴胺 D3 受体配体

• 批准号: 7958344
• 负责人: ROGER D SPEALMAN
• 金额: $ 1.27万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7958344
• 关键词: Agonist; Behavioral; Computer Retrieval of Information on Scientific Projects Database; Disease; Funding; Grant; Institution; Ligands; Molecular; New England; Primates; Research; Research Personnel; Resources; Source; Substance abuse problem; United States National Institutes of Health; base; dopamine D3 receptor

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This project investigates at the molecular through behavioral levels the utility of dopamine D3 receptor antagonists and partial agonists for the treatment of substance abuse disorders.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 该项目从分子和行为水平研究多巴胺 D3 受体拮抗剂和部分激动剂在治疗药物滥用障碍中的效用。